
Patients facing advanced cancer diagnoses often search for last-ditch treatments, and then suddenly see ads promising “personalized” or “next-level” care that a hospital supposedly cannot match. Some of those ads point to clinics that may quote a base price that can climb later and offer treatments the FDA has not approved.
The Lyon Firm is investigating whether certain alternative cancer clinics used misleading marketing to draw in patients and their families. If you or a loved one has been misled into signing up for an alternative cancer treatment and feel taken advantage of, contact our consumer fraud attorneys for a free consultation.
Online advertising reaches new patients very quickly and the profit margins for clinics can be massive. Researchers have investigated alternative medicine ads closely and a 2023 study found 310 paid ads from 11 alternative cancer clinics on Facebook, Instagram and Messenger, many built around the words “natural” and “alternative.” A 2024 review of Google listings for 47 prominent clinics found that about 13 percent told searchers they were alternative providers.
In 2022, MIT Technology Review reported on social media ads that promoted a vitamin C based product and suggested patients travel to a clinic in Mexico to get it. The reporter noted that the product is not FDA approved and not available in the United States.
Meta told the publication it removed several of the ads for violating its misleading claims policy. The FDA says sellers of illegal cancer therapies often rely on exaggerated and false claims.
Insurance rarely covers these kinds of alternative clinics, so patients often pay out of pocket or turn to crowdfunding. The MIT reporting described one fundraiser that showed a “base amount” of $36,500 for three weeks of inpatient care in Mexico. The total was set to rise once the facility chose a treatment plan.
A 2003 federal case shows how early the money can move. The FTC alleged that a Canadian company required patients to wire $15,000 before they traveled to a Tijuana clinic for a magnetic therapy the agency said did not work. A federal court froze the defendants’ assets and ordered the website shut down. Mexican regulators closed the clinic after finding it used an unapproved treatment.
Our attorneys want to know whether clinics in the U.S. send patients to other countries for unapproved treatments. We want to hear if a clinic has quoted a base package and then added expensive genomic testing, custom compounded medications, extra infusions or charged for longer stays after the patient has already traveled and paid.
The United States, Canada and Mexico formed a health fraud working group in 1994 to address cross-border schemes. At the time, the FTC said operators would not escape enforcement by working in one country while targeting consumers in another.
We are examining whether some providers use geography to their advantage. The pattern under review starts with a U.S. marketing campaign or consultation and ends with a referral to a foreign facility for the procedure itself. Whether that arrangement shifts legal responsibility depends on the facts. Courts may look at where the ads ran, who made the promises, who collected payment and where the patient signed consent forms.
A business or licensed provider that makes false statements to American consumers may still face claims under state consumer protection law.
A recent civil complaint alleges that a clinic’s website presented its approach as better than the standard of care, criticized conventional hospitals and clinical trials, and never disclosed that no peer reviewed evidence supported the procedure the patient received. The complaint pleaded negligent misrepresentation, fraud and lack of informed consent. Those are allegations, and the defendants can contest them.
A patient may have a claim when a provider promises or implies results it cannot support, hides material facts such as unapproved status or serious risks, and collects payment based on those statements.
These clinics may not only take money from families, but the survival rates are often much lower than conventional treatments. A Yale led study in the Journal of the National Cancer Institute found that patients with nonmetastatic breast or colorectal cancer who chose alternative therapy as their only initial treatment were nearly five times as likely to die over a median five year follow up.
The study was observational and examined patients who skipped conventional care entirely, not those who combined both approaches.
Common red flags include the following.
If this sounds familiar, save every ad screenshot, web page, brochure, text message, invoice, consent form and wire receipt. Do not stop treatment your oncologist recommended without talking to your doctor first.
The Lyon Firm handles consumer fraud and medical negligence matters, so we can review the marketing and the care together. Our team investigates deceptive health claims and works to identify who made which promises and who profited from them.
If a clinic misled you or a loved one about a cancer treatment, call (513) 381-2333 or contact The Lyon Firm online for a free, confidential consultation.
Taking the first step doesn’t have to be complicated. In just a few minutes, you can share the basics of your case, and our team will guide you from there: